Laetitia E. Lamberts
Publications by Year
Research Areas
Cancer Research and Treatments, Nanoplatforms for cancer theranostics, Photodynamic Therapy Research Studies, Medical Imaging Techniques and Applications, HER2/EGFR in Cancer Research
Most-Cited Works
- → Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial(2015)343 cited
- → Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study(2016)280 cited
- → Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9(2011)129 cited
- → Phase I Study of DMOT4039A, an Antibody–Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer(2016)107 cited
- → Antibody Positron Emission Tomography Imaging in Anticancer Drug Development(2015)102 cited
- → ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment(2015)96 cited
- → 89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors(2017)69 cited
- → HER3, serious partner in crime(2014)63 cited
- → Immune-mediated diseases in primary sclerosing cholangitis(2011)46 cited
- → Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer(2016)43 cited